Burning Rock Biotech Releases Q4 Financial Results
Friday, 29 March 2024, 06:47
Burning Rock Biotech Q4 Earnings Report
Burning Rock Biotech press release (BNR): Q4 GAAP EPS of -$0.22. Revenue of $17.1M (-14.9% Y/Y).
Cash, cash equivalents, restricted cash were $86.7 million as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.